Pathstone Family Office’s Carter's CRI Stock Holding History
Bought
Maintained
Sold
Other funds holding CRI
SCM
BTW
Pathstone Family Office's CRI Position: Q3 2023 in Review
Pathstone Family Office increased its Carter's (CRI) stake by 57% in Q3 2023, buying an estimated $250K and bringing the position to 9,646 shares worth $667K. The position accounts for 0.01% of the portfolio, ranked #891.
Pathstone Family Office first reported a position in CRI in Q1 2018 and has held it in 12 quarters since. The position peaked at $804K in Q4 2022. 301 funds tracked by Wall St. Rank hold CRI as of Q3 2023.
- Pathstone Family Office held 9,646 shares of Carter's worth $667K as of Q3 2023.
- Pathstone Family Office bought 3,504 Carter's shares in Q3 2023, an estimated $250K.
- Carter's made up 0.01% of Pathstone Family Office's portfolio in Q3 2023, its #891 holding.
- Pathstone Family Office first reported a position in Carter's in Q1 2018 and has held it in 12 quarters since.
- Pathstone Family Office's Carter's position peaked at $804K in Q4 2022.
- 301 funds tracked by Wall St. Rank held Carter's as of Q3 2023.
Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.